1 |
Celli BR, Wedzicha JA. Update on clinical aspects of chronic obstructive pulmonary disease[J]. N Engl J Med, 2019, 381(13): 1257-1266.
|
2 |
张 灵,杨 荀,蒋水平,等. 老年慢性阻塞性肺疾病诊断与治疗新进展[J/CD]. 中华肺部疾病杂志(电子版), 2023, 16(2): 285-289.
|
3 |
Gillissen A, Gessner C, Hechenbichler K, et al. Patient satisfaction and clinical outcomes with budesonide plus formoterol spiromax for asthma and chronic obstructive pulmonary disease: A real-world, observational trial[J]. Respiration, 2019, 97(4): 292-301.
|
4 |
谢汰钟,隆 红. 中西药合用治疗慢性阻塞性肺疾病稳定期肺肾气阴两虚型疗效分析[J]. 实用中医药杂志,2019, 35(12): 1503-1504.
|
5 |
王荣宝,杨翠萍,祝 晶. 补肺纳肾平喘方联合信必可治疗哮喘—慢性阻塞性肺疾病重叠综合征[J]. 吉林中医药,2019, 39(2): 212-215.
|
6 |
Zhou M, Jiao L, Liu Y. sFRP2 promotes airway inflammation and Th17/Treg imbalance in COPD via Wnt/β-catenin pathway[J]. Respir Physiol Neurobiol, 2019, 17(270): 103282.
|
7 |
中华医学会,中华医学会杂志社,中华医学会全科医学分会,等. 慢性阻塞性肺疾病基层诊疗指南(2018年)[J]. 中华全科医师杂志,2018, 17(11): 856-870.
|
8 |
中华中医药学会内科分会肺系病专业委员会. 慢性阻塞性肺疾病中医诊疗指南(2011版)[J]. 中医杂志,2012, 53(1): 80-84.
|
9 |
方 森,黄 乐,柏正平,等. 慢性阻塞性肺疾病中医药治疗临床疗效评价方法之策略[J]. 中医药导报,2020, 26(5): 110-112.
|
10 |
Ritchie AI, Wedzicha JA. Definition, causes, pathogenesis, and consequences of chronic obstructive pulmonary disease exacerbations[J]. Clin Chest Med, 2020, 41(3): 421-438.
|
11 |
王 宁,栗 娜,韩巧玲,等. 布地奈德福莫特罗联合噻托溴铵治疗哮喘-慢性阻塞性肺疾病重叠的临床研究[J]. 中国综合临床,2021, 37(1): 39-45.
|
12 |
Bagherisadeghi G, Chrystyn H, Abadelah M, et al. Real-life budesonide and formoterol dose emission from the medium and high strength fixed dosed combinations in a Spiromax® dry powder inhaler using inhalation profiles from patients with chronic obstructive pulmonary disease[J]. Eur J Pharm Sci, 2019, 21(139): 105059.
|
13 |
张艳丽,都爱博,苏 军,等.自拟滋阴养肺汤治疗气阴两虚型慢性阻塞性肺疾病稳定期患者72例[J]. 环球中医药,2019, 12(6): 900-903.
|
14 |
张慧琪. 清燥救肺汤加味治疗气阴两虚证哮喘-慢性阻塞性肺疾病重叠综合征的疗效观察[J]. 辽宁中医杂志,2019, 46(4): 759-762.
|
15 |
赵园园,谭光波,梁成照. 补肺益肾法治疗慢性阻塞性肺疾病的Meta分析[J]. 海南医学院学报,2021, 27(2): 121-128, 137.
|
16 |
刘中民. 益气补肺汤对稳定期慢性阻塞性肺疾病患者肺功能及炎性因子的影响[J]. 国医论坛,2019, 34(3): 17-19.
|
17 |
Lourenço JD, Teodoro WR, Barbeiro DF, et al. Th17/Treg-related intracellular signaling in patients with chronic obstructive pulmonary disease: Comparison between local and systemic responses[J].Cells, 2021, 10(7): 1569.
|
18 |
Wang C, Wang H, Dai L, et al. T-Helper 17 Cell/regulatory T-cell imbalance in COPD combined with T2DM patients[J]. Int J Chron Obstruct Pulmon Dis, 2021, 15(16): 1425-1435.
|
19 |
骆碧君,魏居瑞,吴 杰,等. 补肺纳肾汤在慢性阻塞性肺疾病稳定期的应用效果观察[J]. 中国中医药科技,2020, 27(6): 935-936.
|
20 |
杨 艺,钱 堃. 补肺纳肾汤联合西药治疗慢性阻塞性肺气肿稳定期临床研究[J]. 新中医,2019, 51(12): 106-108.
|
21 |
王燕芳. 补肺益肾汤治疗慢性阻塞性肺疾病稳定期肺肾气虚型患者的临床研究[J]. 中国中医药科技,2020, 27(4): 506-508.
|
22 |
郭永彬,胡绍丰,张立明,等. 补肺益肾汤治疗支气管哮喘缓解期的效果观察[J]. 中国临床医生杂志,2021, 49(5): 618-622.
|